{"acquisitions":[],"changes":[],"country":"US","description":"Poplar Therapeutics develops pharmaceutical treatments focused on new anti-IgE medicines to help patients manage allergic conditions. Its audience includes patients with anti-IgE-treatable conditions, healthcare professionals, and investors. Its edge is targeting therapies that aim to push beyond the limits of existing anti-IgE treatments.","domain":"poplartx.com","employees":null,"founded":2024,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.787936,"lng":-122.40752,"location":"San Francisco","multiples":[],"name":"Poplar Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":50000000,"connectionsAmong":[],"currency":"USD","date":"2026-01-07","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"poplartx-com-2026-01-07-series-a","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-12","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"poplartx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-12","status":"attributed","url":null},{"fact":"existence","publisher":"poplartx.com","retrievedAt":"2026-06-12","status":"self-reported","url":"https://poplartx.com"},{"fact":"description","publisher":"poplartx.com","retrievedAt":"2026-06-12","status":"self-reported","url":"https://poplartx.com"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["astra 4.12.0","cloudflare","cloudflare bot management","doubleclick floodlight","google analytics","google tag manager","gravity forms 2.10.3","gutenberg","http/3","mysql","php","spectra 2.19.17"],"totalRaisedUsd":50000000,"traction":[],"updatedAt":"2026-06-12","valuations":[]}